Stay updated on ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Sign up to get notified when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.

Latest updates to the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, v3.6.4, was added to the study's revision history and the previous v3.6.3 entry is removed from the visible history, reflecting an update to the record's versioning. This indicates an update to the study's revision metadata.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history page now lists Revision: v3.6.3, replacing the previous v3.6.2. This indicates a platform release update rather than changes to study information.SummaryDifference0.1%

- Check30 days agoChange DetectedA new revision tag v3.6.2 is added to the study record history and the previous v3.6.0 tag is removed, reflecting a minor update to the page's versioning.SummaryDifference0.1%

- Check44 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating accrual has ended for this study. The history now shows revision v3.6.0 as the current version, with v3.5.5 removed from the record history.SummaryDifference0.5%

- Check51 days agoChange DetectedThe Record History page now includes a new revision entry labeled v3.5.5, indicating an update to the page's revision history. The previous revision label v3.5.4 has been removed from the current change list, reflecting the latest version tracking for the study record.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision label v3.5.4 was added to the page history, replacing v3.5.3. This reflects an update to the page's revision metadata in the study record history.SummaryDifference0.1%

Stay in the know with updates to ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.